Key facts
- This page summarizes Michael E. Prevoznik's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Sep 2024, 16:30.
Michael E. Prevoznik - 29 Aug 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- SVP & General Counsel
- Issuer ticker
- DGX
- Reported as of
- 29 Aug 2024
- Net transaction value
- -$5,044,516
- SEC form
- 4
- Accepted by SEC
- 03 Sep 2024, 16:30:57 UTC
- Prior SEC filing
- 01 Mar 2024
- Next SEC filing
- 02 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael E. Prevoznik filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 03 Sep 2024.
Change
- Previous filing in this sequence was filed on 01 Mar 2024.
- Current net transaction value: -$5,044,516.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Options Exercise
- Transaction value
- $3,118,223
- Shares
- +32,551
- Change %
- +85%
- Price
- $95.80
- Shares after
- 71,029
- Date
- 29 Aug 2024
- Ownership
- Direct
DGX
transaction
Common Stock
Sale
- Transaction value
- $5,044,516
- Shares
- -32,551
- Change %
- -46%
- Price
- $154.97
- Shares after
- 38,478
- Date
- 29 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
DGX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,592
- Date
- 29 Aug 2024
- Ownership
- 401(k)/SDCP
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DGX
transaction
Derivative
Non-Qualifed Stock Option (right to buy)
Options Exercise
- Transaction value
- $3,118,223
- Shares
- -32,551
- Change %
- -100%
- Price
- $95.80
- Shares after
- 0
- Date
- 29 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 32,551
- Exercise price
- $95.80
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This transaction was executed in multiple trades at prices ranging from $154.890 to $155.455. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F2
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Footnote F3
The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020.